As an aromatase inhibitor, Armotraz Tablet reduces estrogen production in the body. The medication can be administered with or without meals, though maintaining consistent daily dosing timing optimizes therapeutic outcomes. Strict adherence to your physician’s prescribed regimen is essential. Dosage frequency and strength are determined by your specific condition. The tablets should be swallowed intact with water. Continue treatment for the full prescribed duration.
Common adverse effects may include hot flashes, nausea, skin eruptions, arthralgia, bone density loss, and fatigue. Consult your healthcare provider if these symptoms become bothersome or severe, as management strategies may be available.
Prior to initiating therapy, disclose if you’re premenopausal with active menstruation or have hepatic/renal impairment. Provide a complete list of current medications as certain drugs may diminish efficacy or alter pharmacokinetics. Pregnancy and lactation status should be communicated. Your physician may monitor vitamin D levels and bone mineral density through periodic testing.
THERAPEUTIC INDICATIONS
- Management of breast carcinoma
CLINICAL BENEFITS
In Breast Cancer Management
ADVERSE EFFECTS PROFILE
Frequently Reported Reactions
- Vasomotor symptoms (hot flashes)
- Gastrointestinal discomfort
- Decreased bone mineralization
- Cutaneous eruptions
- Asthenia
ADMINISTRATION GUIDELINES
PHARMACOLOGICAL ACTION
Important Notice:
This information is provided for educational purposes after rigorous medical review. However, it does not substitute professional medical advice, diagnosis, or treatment. The content may not encompass all potential adverse effects, contraindications, or drug interactions. Always consult your healthcare provider regarding any medical condition or therapeutic regimen. This material aims to complement, not replace, the crucial relationship between patients and their physicians.
Reviews
There are no reviews yet